Kiyoto Naito, Hiroyuki Fujii, Eri Inoue, T. Yoshii, M. Shinohara, Shinichi Yamaguchi
{"title":"血管紧张素Ⅱ1型受体阻滞剂和钙通道阻滞剂引起高钾血症的风险:基于日本医学信息库的回顾性队列研究","authors":"Kiyoto Naito, Hiroyuki Fujii, Eri Inoue, T. Yoshii, M. Shinohara, Shinichi Yamaguchi","doi":"10.3820/jjpe.26.e5","DOIUrl":null,"url":null,"abstract":"baseline serum potassium levels affected the onset of the disease in clinical practice. Previous studies also reported the effects of renal insufficiency and other factors on the onset of hyperkalemia. ARB should be prescribed carefully in patients with these factors, as is conventionally done. science","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of Hyperkalemia due to the Administration of Angiotensin Ⅱ Type 1 Receptor Blocker and Calcium Channel Blocker： Retrospective Cohort Study Based on Japanese Medical Information Database.\",\"authors\":\"Kiyoto Naito, Hiroyuki Fujii, Eri Inoue, T. Yoshii, M. Shinohara, Shinichi Yamaguchi\",\"doi\":\"10.3820/jjpe.26.e5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"baseline serum potassium levels affected the onset of the disease in clinical practice. Previous studies also reported the effects of renal insufficiency and other factors on the onset of hyperkalemia. ARB should be prescribed carefully in patients with these factors, as is conventionally done. science\",\"PeriodicalId\":14576,\"journal\":{\"name\":\"Japanese Journal of Pharmacoepidemiology\\\\/yakuzai Ekigaku\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Pharmacoepidemiology\\\\/yakuzai Ekigaku\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3820/jjpe.26.e5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3820/jjpe.26.e5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Risk of Hyperkalemia due to the Administration of Angiotensin Ⅱ Type 1 Receptor Blocker and Calcium Channel Blocker： Retrospective Cohort Study Based on Japanese Medical Information Database.
baseline serum potassium levels affected the onset of the disease in clinical practice. Previous studies also reported the effects of renal insufficiency and other factors on the onset of hyperkalemia. ARB should be prescribed carefully in patients with these factors, as is conventionally done. science
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
